📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management. (2024)

First Author: Zuberbier T

Attributed to: MICA: Identifying risks for severe life-threatening allergic reactions to foods (IRIS-Allergy) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/clt2.70002

PubMed Identifier: 39506193

Publication URI: http://europepmc.org/abstract/MED/39506193

Type: Journal Article/Review

Volume: 14

Parent Publication: Clinical and translational allergy

Issue: 11

ISSN: 2045-7022